Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J. P. Morgan Small/Mid Cap Conference

November 23, 2009 at 4:28 PM EST

SUNNYVALE, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the 21st Annual Piper Jaffray Healthcare Conference in New York on Tuesday, December 1, 2009 at 9:00 a.m. ET/6:00 a.m. PT. The company will also present at the J. P. Morgan Small/Mid Cap Conference in New York on Thursday, December 3, 2009 at 3:00 p.m. ET/12:00 p.m. PT.

A live webcast of each presentation will be available online from the investor relations page of the Company's Web site at http://www.accuray.com. The webcast replay of the presentations will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.

About the CyberKnife® Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 70,000 patients worldwide and currently 180 Systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit www.accuray.com.

SOURCE Accuray Incorporated

Investors, Tom Rathjen, Vice President, Investor Relations, +1-408-789-4458, trathjen@accuray.com, or Media, Stephanie Tomei, Senior Manager, Marketing Communications, +1-408-789-4234, stomei@accuray.com, both of Accuray Incorporated